Navigation Links
Doctors Treat Early Heart Attacks Before Labs Could Confirmation It

to determine if these patients with early symptoms were being treated the same as patients who were known to be having a heart attack, or if the doctors were waiting for elevated heart markers before beginning treatment,” said Miller. “Our findings suggest that doctors were treating both of these high-risk patient groups the same and were not waiting for the heart markers to elevate.”

The results showed that in both groups that had heart attacks, doctors treated patients with aspirin and other blood-thinning medications. The groups also had similar rates of angioplasty, a procedure to open blocked arteries, and surgery to “bypass” blocked arteries.

Miller said the results suggest that doctors are using other immediately available data, such as information from the patient's history and electrocardiogram, to make treatment decisions.

The researchers also found that those patients who were having an “evolving” heart attack were 19 percent less likely to die or have a second heart attack within 30 days than patients who were immediately diagnosed with a heart attack. Although the exact reason for this finding cannot be determined from this research, this finding could be due to earlier treatment, said Miller. The patients with “evolving” heart attacks came to the emergency department a median of 1.7 hours after their symptoms developed, compared to 4 hours for those whose heart attack markers had already increased.

Of the 8,312 patients in the study, 66 percent were diagnosed with a heart attack at enrollment, 20 percent had an “evolving” heart attack that showed up on lab tests within 12 hours and 13 percent of participants didn’t have elevated markers within 12 hours.

The research was an analysis of a larger trial, the Superior Yield of the New strategy of Enoxaparin, Revascularization, and GlYcoprotein IIb/IIIa inhibitors (SYNERGY) trial. The study included patients who met two of the following criteria:
'"/>




Page: 1 2 3

Related medicine news :

1. Cancer Doctors Okays Controversial Prostate Therapy
2. Doctors needed urgently in Gujarat
3. Doctors operate upon patients in candlelight- latest from the quake scene
4. Doctors at risk- the ugly side of the noble profession
5. Doctors advice early anemia tests
6. Emphasis to ban Drugs ads by Doctors
7. Doctors not to accept gifts from drug companies
8. Gene testing kit specific for Doctors
9. Doctors warned of fluoride toxicity
10. Doctors decisions are affected by fear of lawsuits- says a study
11. Bihar High Court Intervenes To End Doctors Strike
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Doctors Treat Early Heart Attacks Before Labs Could Confirmation

(Date:3/5/2015)... March 05, 2015 At the ... Beyond,” leaders in addiction treatment met today in Jackson, ... best clinical practices. Among the numerous respected speakers will ... will address the role that pain medications have had ... evidence-based treatment options. , "It is hard to believe ...
(Date:3/5/2015)... Taking center stage at the Fort ... 9-11th is IDRevolution hosted by IDLife LLC, a ... IDLife offers a variety of nutritional products including ... to vitamin supplementation is based upon the latest ... compliant online assessment and ends with a truly ...
(Date:3/5/2015)... Harrisburg, NC (PRWEB) March 05, 2015 ... of Physician Assistants’ (AAPA) review of Clearstream, ... AAPA determined that Clearstream’s MediDefense line of products—led ... of the AAPA’s Affinity Partner Program. , The ... physician assistants across all medical and surgical specialties ...
(Date:3/5/2015)... Jordan, Utah (PRWEB) March 05, 2015 ... defibrillator by LifeVest® as a treatment option for sudden ... continuously monitors heart rhythm and can detect any life-threatening ... device will alert the patient before delivering a treatment ... , Dr. Adam Elhaddi of Jordan Valley Medical Center ...
(Date:3/5/2015)... 05, 2015 Altec Products, Inc., a ... today their participation in the Houston, TX and Charlotte, ... Inspire Tour will unite Sage enterprise resource planning (ERP) ... workable solutions to real-world business challenges. , The ... Plaza Houston Galleria Area on March 10th. The Charlotte, ...
Breaking Medicine News(10 mins):Health News:National Addiction Treatment Expert William S. “Bill” Jacobs, Md Speaks At Prestigious 7th Annual Mississippi Addiction Conference 2Health News:National Addiction Treatment Expert William S. “Bill” Jacobs, Md Speaks At Prestigious 7th Annual Mississippi Addiction Conference 3Health News:IDLife Partners John C. Maxwell and Troy Aikman speaking at IDRevolution in Fort Worth, TX April 9th-11th, 2015 2Health News:Clearstream’s Line of MediDefense Antimicrobial Products Scores Affinity Partnership With American Academy of Physician Assistants (AAPA) 2Health News:Clearstream’s Line of MediDefense Antimicrobial Products Scores Affinity Partnership With American Academy of Physician Assistants (AAPA) 3Health News:Clearstream’s Line of MediDefense Antimicrobial Products Scores Affinity Partnership With American Academy of Physician Assistants (AAPA) 4Health News:New Technology Behind LifeVest® Wearable Defibrillator Saves the Life of Utah Man in Cardiac Arrest 2Health News:New Technology Behind LifeVest® Wearable Defibrillator Saves the Life of Utah Man in Cardiac Arrest 3Health News:Altec Attends Sage Inspire Tour Stops in Houston and Charlotte to Showcase Sage ERP Document Management and Workflow Solution 2Health News:Altec Attends Sage Inspire Tour Stops in Houston and Charlotte to Showcase Sage ERP Document Management and Workflow Solution 3
... worlds largest publisher of open access journals, is ... Magnetic Resonance (JCMR) is moving to BioMed Centrals ... publishers, Taylor & Francis. The move from a ... Society of Cardiovascular Magnetic Resonance (SCMR) members and ...
... OCALA, Fla., Dec. 12 Franck,s Compounding Lab ... Pharmacy Services in,Woodruff, Wisconsin. Island Pharmacy owners, Randy ... other personal interests. Selling their,pharmacy to Franck,s Compounding ... ensure the continuance of high quality prescriptions and ...
... up with community based, organizations and Babies "R" Us to help ... ... little ones, MERRILLVILLE, Ind., Dec. 12 With a traditional ... afternoon when,Anthem Blue Cross and Blue Shield hosts a community-wide baby ...
... fighting gum disease , , WEDNESDAY, Dec. 12 (HealthDay ... infections, and a weakened immune response may be to ... , In experiments with mice infected with the bacteria ... to battle gum infection than their normal-weight counterparts, according ...
... Austria, December 12 f-star, an antibody,engineering company ... unique Modular Antibody Technology, announced today that it,has ... three,outstanding scientists to form the nucleus of this ... Professor Sir Ravinder Maini, Imperial College, London, ...
... organizations in ... underserved areas, WOODLAND HILLS, Calif., Dec. 11 ... $30,000 in end of,year donations to various food banks throughout California. An ... and,southern California to assist vulnerable populations., Blue Cross employees will visit ...
Cached Medicine News:Health News:Society of Cardiovascular Magnetic Resonance chooses open access 2Health News:Anthem Blue Cross and Blue Shield Celebrates Local Moms-to-Be at Community Baby Shower 2Health News:Anthem Blue Cross and Blue Shield Celebrates Local Moms-to-Be at Community Baby Shower 3Health News:Obesity Weakens Immune Response 2Health News:Antibody Engineering Company f-star Appoints Three Pioneers in Antibody Engineering and Development to its Newly Established Scientific Advisory Board 2Health News:Antibody Engineering Company f-star Appoints Three Pioneers in Antibody Engineering and Development to its Newly Established Scientific Advisory Board 3Health News:Blue Cross of California Gives $30,000 in Holiday Donations to Food Banks Throughout the State 2
(Date:3/5/2015)... N.Y. , March 5, 2015  AMRI (NASDAQ: ... Pettersson , fills the newly created position of VP ... Christopher Conway , Senior Vice President of Global Sales ... Pettersson will lead the international sales team in an ... share in targeted market segments. Mr. Pettersson will drive ...
(Date:3/5/2015)... 2015 LUNGevity Foundation, the nation,s leading ... Administration,s (FDA) approval of Bristol Myers Squibb,s new ... treatments add another critical new treatment option to ... a patient,s own immune system to fight cancerous ... for patients with squamous cell lung cancer, a ...
(Date:3/5/2015)... DUBLIN , Mar. 05, 2015 Research ... announced the addition of the "Global Pharma ... and Cost Optimization Plays Major Role In Shaping ... report to their offering. Strategy ... resulting in healthy Cash position- Will accelerate Next ...
Breaking Medicine Technology:AMRI Hires VP of International Sales 2LUNGevity Foundation Applauds FDA Approval of Immunotherapy Drug Opdivo 2LUNGevity Foundation Applauds FDA Approval of Immunotherapy Drug Opdivo 3Global Pharma US & EU Outlook 2015: First -In-Class Innovations and Cost Optimization Plays Major Role In Shaping Up Business for Large Cap Pharmaceutical Companies 2Global Pharma US & EU Outlook 2015: First -In-Class Innovations and Cost Optimization Plays Major Role In Shaping Up Business for Large Cap Pharmaceutical Companies 3
... Company to Submit a Supplemental New Drug Application to ... Cephalon, Inc . (Nasdaq: CEPH ... clinical trial of NUVIGIL(R) (armodafinil) Tablets [C-IV] as a ... Based on these findings, Cephalon(R) will file a ...
... today announced that the Endocrinologic and Metabolic Drugs Advisory Committee ... finalized its discussions of questions related to liraglutide, a once-daily ... to the risk profile of liraglutide. , , ... A majority of Advisory Committee members supported that appropriate evidence ...
Cached Medicine Technology:Cephalon Announces Positive Results from a Phase Three Study of NUVIGIL in Jet Lag Disorder 2Cephalon Announces Positive Results from a Phase Three Study of NUVIGIL in Jet Lag Disorder 3Cephalon Announces Positive Results from a Phase Three Study of NUVIGIL in Jet Lag Disorder 4Update on FDA Advisory Committee Meeting on Liraglutide for the Treatment of Type 2 Diabetes 2Update on FDA Advisory Committee Meeting on Liraglutide for the Treatment of Type 2 Diabetes 3
Williger periosteal elevator, 6 1/4", sharp, 5 mm wide....
Sedillot periosteal elevator, 16 mm, sharp, 7"....
Dolwick-Reich Condyle periosteal elevator, 17.5 cm, 7"....
Periosteal elevator #9H, 17.5 cm, 7"....
Medicine Products: